Antimycobacterial activity and possible mode of action of newly isolated neodiospyrin and other naphthoquinones from Euclea natalensis  by van der Kooy, F. et al.
ny 72 (2006) 349–352
www.elsevier.com/locate/sajbSouth African Journal of BotaAntimycobacterial activity and possible mode of action of newly isolated
neodiospyrin and other naphthoquinones from Euclea natalensis
F. van der Kooy ⁎, J.J.M. Meyer, N. Lall
Department of Botany, University of Pretoria, Pretoria, 0002, South Africa
Received 19 September 2005; received in revised form 26 September 2005; accepted 8 March 2006Abstract
The roots of Euclea natalensis are used by the indigenous people of southern Africa against various bacterial infections. Six naphthoquinones;
diospyrin, isodiospyrin, mamegakinone, 7-methyljuglone, neodiospyrin and shinanolone were isolated from root extracts of this plant. In the case
of neodiospyrin, this was a first time isolate. The activity of the six isolated compounds were tested against Mycobacterium tuberculosis using the
radiometric BACTEC assay, providing a first report on the antimycobacterial activity of isodiospyrin, neodiospyrin and mamegakinone. The MIC
values of diospyrin (8.0 μg/ml), isodiospyrin (10.0 μg/ml), 7-methyljuglone (0.5 μg/ml) and neodiospyrin (10.0 μg/ml) compared well to those of
the known antimycobacterial drugs, ethambutol, isoniazid and rifampicin. A hypothesis on the structure-activity relationship for the
naphthoquinones and a possible mode of action is discussed.
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Euclea natalensis is a shrub or small to medium size tree,
which occurs in a variety of habitats, including coastal and
inland forests as well as bushveld in southern Africa (Van Wyk
and Van Wyk, 1997). The roots of E. natalensis are used by
indigenous people of southern Africa for various bacterial
infections (Watt and Breyer-Brandwijk, 1962). Powdered root
bark of this species is used as an ingredient in medicines to treat
urinary tract infections, venereal diseases and dysmenorrhoea.
The custom of cleaning teeth and gums with chewed roots of E.
natalensis is also practiced widely (Stander and Van Wyk,
1991). The Zulu of South Africa use the root bark to treat TB-
related symptoms such as chest diseases, bronchitis, pleurisy
and asthma (Watt and Breyer-Brandwijk, 1962).
Several secondary metabolites have been isolated from E.
natalensis (van der Vijver and Gerritsma, 1974; Ferreira et al.,
1977; Lall and Meyer, 2001). Nine of these compounds are
naphthoquinones. Other compounds include dihydroxyursanoic
acids (lactone derivatives), triterpenoids and one tetrahydroxy-
flavanone arabinopyranoside. We report here on a newly⁎ Corresponding author.
E-mail address: fkooy@scientia.up.ac.za (F. van der Kooy).
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doi:10.1016/j.sajb.2005.09.009isolated napthopquinone from root extracts and MIC values of
six naphthoquinones against Mycobacterium tuberculosis.
2. Materials and methods
2.1. Plant material
E. natalensis A.DC. (Ebenaceae) root material was collected
in the KwaZulu-Natal province of South Africa. The samples
were similar to a voucher specimen (N.L.22), which was
deposited at the H.G.W.J. Schweickerdt herbarium at the
University of Pretoria.
2.2. Isolation of active compounds
The root material was air-dried at room temperature for one
week and ground into a fine powder. The powdered root
material (1.5 kg) was extracted with 10 L of chloroform for 48 h
at room temperature. The solid residues were filtered off and re-
extracted in 10 L chloroform. This procedure was repeated three
times. Using a rotary-evaporator the extract was dried at 40 °C
to yield 25 g of crude extract (yield 1.7%). A silica gel (Merck,
0.063–0.200 mm, 1.5 kg) column was prepared and the crude
extract (25 g) was fractionated (Fig. 1) with a 9:1 hexane: ethylts reserved.
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Fig. 1. The chromatographic steps followed to isolate the six naphthoquinones.
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ratio (1.5 L) until a 1:1 ratio was reached. The eluting fractions
(121) were spotted on a TLC plate (Merck, Kieselgel F256,
20×20 cm) and subjected to UV scrutiny. According to the TLC
profiles fractions 5–39 (11.0 g), 41–87 (1.5 g) and 89–121
(1.7 g) were pooled. These fractions were re-chromatographed
with silica gel and Sephadex LH-20 (100 g) to yield six
compounds (Fig. 2). The yields of the six isolated compounds
were: diospyrin (460 mg), isodiospyrin (69 mg), mamegakinone
(153 mg), 7-methyljuglone (265 mg), neodiospyrin (55 mg),
shinanolone (490 mg).
2.3. Antimycobacterial bioassay
A susceptible strain of M. tuberculosis H37Rv, obtained
from the American Type Culture Collection (Rockville, MD,
USA), was used to investigate the activity of the purified
naphthoquinones. The 7H12 Middlebrook TB medium (Mid-
dlebrook et al., 1977) used during these studies consisted of an
enriched Middlebrook 7H9 broth base supplemented with
bovine serum albumin, catalase, casein hydrolysate and 14C-
labelled substrate (palmitic acid) as a source of carbon. Growth
of the mycobacterium leads to the consumption of the carbon
source, with subsequent release of labelled 14CO2. This labelled
CO2 moves into the atmosphere above the medium in the sealed
vial and the BACTEC TB 460 instrument detects the amount of
14CO2 and records it as a growth index (GI) on a scale of 0–999
(Heifets and Good, 1994).For the MIC determination, a vial containing 7H12
Middlebrook TB medium was inoculated with homogenised
cultures in a special diluting fluid (Middlebrook–Dubos 7H9
broth having the no. 1 McFarland standard optical density).
When growth in this vial reached a GI reading of 400–500,
the 7H12 broth culture was used undiluted to inoculate a set of
vials. The isolated compounds, dissolved in dimethylsulfoxide
(DMSO), were added into the vials to give a final
concentration of 1% DMSO. The positive drug controls
ethambutol, izoniazid and rifampicin and a 1% DMSO control
were used.
Inoculated vials were incubated at 38 °C and each vial was
assayed daily at the same hour until cumulative results were
interpretable. The GI value of the control vial was compared
with the readings from the vials containing the compounds. The
control vial contains a 1:100 dilution of the inoculum and when
it reached a reading of 30 the readings were stopped. The
difference in GI readings for the last two days (ΔGI) was used.
If ΔGI readings of any of the compounds were less than the
control vial, that compound was considered to be active. All
compounds were tested in triplicate.
3. Results
3.1. Isolated compounds
Diospyrin, 7-methyljuglone and shinanolone were identified
by means of TLC and HPLC in the presence of reference
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Fig. 2. Chemical structures of the six naphthoquinones isolated. The numbering
system is indicated for diospyrin.
Table 2
Minimum inhibitory concentrations (MIC) on the H37Rv Mycobacterium
tuberculosis strain, of isolated naphthoquinones and the antimycobacterial
drugs, isoniazid, rifampicin and ethambutol
Compound MIC (μg/ml) Lowest concentration tested (μg/ml)
Isoniazid 0.062 0.016
Rifampicin 0.125 0.063
Ethambutol 1.250 0.625
Diospyrin 8.000 5.000
Isodiospyrin 10.000 5.000
Mamegakinone 100.000 50.000
7-methyljuglone 0.500 0.250
Neodiospyrin 10.000 5.000
Shinanolone 100.000 10.000
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compounds and the results compared to published data (Lillie
and Musgrave, 1977). Isodiospyrin, mamegakinone and
neodiospyrin were identified by means of 1H NMR and
compared to published results (Lillie and Musgrave, 1977;
Kumari et al., 1982). The 1H NMR chemical shifts of the
isolated naphthoquinones are shown in Table 1.Table 1
The proton chemical shifts of the isolated naphthoquinones as analysed on a 300 M
Compound Ring Chemical shifts
H-1 H-2 H-3
Diospyrin A 6.88
B 6.93 6.93
Isodiospyrin A 6.70 d j=10.4 6.90 d
B 6.93 6.92
Mamegakinone A 6.96
7-methyljuglone A 6.89 6.89
Neodiospyrin A 6.76 d j=10.4 6.92 d
B 6.60
Shinanolone A 4.80 dd
j=3.7, 7.3
2.11 mp (equa.)
2.25 mp (axial)
2.57 m
2.87 m
The ring system refers to the naphthalene molecule in the naphthoquinones. d = duple
in Hz.3.2. Antimycobacterial activity
The MIC values of the isolated naphthoquinones are given in
Table 2. The activity of 7-methyljuglone (MIC=0.5 μg/ml) was
found to be comparable to rifampicin and better than
ethambutol. The naphthoquinones; diospyrin, isodiospyrin
and neodiospyrin showed good activity with mamegakinone
and shinanolone showing the least activity at 100 μg/ml.
4. Discussion
During this study neodiospyrin was newly isolated from E.
natalensis. The minimum inhibitory concentration (MIC) of
only three of the naphthoquinones (diospyrin, 7-methyljuglone
and shinanolone) has previously been reported for a drug-
sensitive strain of Mycobacterium tuberculosis (Weigenand et
al., 2004; Lall et al., 2005). The results showed that the
naphthoquinones tested have good activity against M.
tuberculosis when compared to the positive drug controls.
The MICs of the naphthoquinones indicate that the ketone
groups on C1 and C4 are important for antimycobacterial
activity. This can be seen by comparing the activity of 7-
methyljuglone (MIC=0.5 μg/ml) with shinanolone (MIC=
100.0 μg/ml). The ketone group on carbon 1 of shinanolone is
reduced to the corresponding hydroxyl group. The lack of
aromaticity between carbons 1 and 4 might also play a role inHz spectrometer in CDCl3
H-6 7-Me H-8 5-OH
7.11 bd j=∼1 2.43 7.49 bd j=∼1 11.85
2.29 7.54 12.11
j=10.4 7.28 2.01 7.59 12.41
2.0 12.03
7.11 bd j=∼1 2.45 7.48 bd j=∼1 11.70
7.06 2.42 7.43 11.83
j=10.4 7.25 2.28 12.27
7.09 bd j=∼1 2.45 7.52 bd j=∼1 11.73
p (equa.)
p (axial)
6.71 2.28 6.82 12.37
t, bd = broad duplet, mp = multiplet, dd = dublet-of-dublet, j = coupling constant
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Fig. 3. The incorporation of 7-methyljuglone into the electron transport chain might cause the electron flow to stop or decrease. Alternatively it might competitively
bind to the Men enzymes with the result that the isoprene side-chain cannot be attached to carbon 2.
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molecules of 7-methyljuglone might be explained by the larger
size of these molecules and that the ketone groups are
hindered to take part in chemical reactions by the three
dimensional shape of the molecule itself. Mamegakinone is
completely blocked in this region, which might be the reason
for its low antimycobacterial activity. The shape of the most
active molecule, 7-methyljuglone, is very similar to menaqui-
none, which is part of the mycobacterial electron transport
system.
Mycobacterium contains the natural redox cycler menaqui-
none, which mediate electron transfer between different
membrane-bound enzymes of the respiratory chain (Garbe,
2004). Most bacteria (including E. coli) and mammals make use
of ubiquinone to fulfill this function. E. coli does however make
use of both forms. According to Truglio et al. (2003) M.
tuberculosis lacks ubiquinone and makes only use of menaqui-
none in the electron transport chain. It is therefore an attractive
drug target because it lacks a human homologue. Due to
structural similarities between 7-methyljuglone and menaqui-
none it is feasible to postulate that 7-methyljuglone can interact
with enzymes in the mycobacterial electron transport chain
(Fig. 3). Due to the difference in the redox potential of the
incorporated 7-methyljuglone, the electron flow might be
slowed or stopped. It is also possible that 7-methyljuglone
binds to the Men enzymes responsible for the formation of
menaquinone and inhibits the addition of the hydrophobic side-
chain. This will influence ATP production and result in a
detrimental effect on the organism.
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